(CIDRAP News) – In a recent update on pandemic influenza preparedness planning, the US government reported meeting more than 90% of a long list of objectives it set for itself about 6 months ago.
The report charts progress on a wide range of preparedness measures, from shoring up laboratory capabilities to planning for distribution of critical medical supplies and preparing checklists for various sectors of the economy.
(CIDRAP News) A 26-year-old Egyptian man died of H5N1 avian influenza today, the World Health Organization (WHO) reported, bringing to 3 the number of deaths from the disease since Christmas Eve.
A 30-year-old woman died Dec 24, and a 15-year-old girl died Dec 25, several media outlets reported. The three patients become Egypt's 16th, 17th, and 18th cases and the country's 8th, 9th, and 10th deaths.
(CIDRAP News) More poultry have died of H5N1 avian influenza in Vietnamese provinces where the virus recently re-emerged, and the disease has spread to another province in South Korea and 3 more Nigerian states, according to news reports.
(CIDRAP News) Scientists who analyzed mortality records from the 1918 influenza pandemic estimate that a similarly severe pandemic today would kill about 62 million people worldwide, the vast majority of them in the developing world.
(CIDRAP News) Government investigators were unable to determine where Canada's latest cow infected with bovine spongiform encephalopathy (BSE) was born, making it impossible to tell how the animal was exposed to the disease or find other cows that might have been exposed, the Canadian government said this week.
(CIDRAP News) The Department of Health and Human Services is seeking help from the public in figuring out how to allocate scarce supplies of influenza vaccine in the event of a flu pandemic.
In a Dec 14 Federal Register notice, HHS invited the public to submit comments on which groups should have priority for receiving pre-pandemic and pandemic vaccines and on related issues. The deadline for commenting is Jan 18, 2007.
(CIDRAP News) The US government yesterday canceled its $877.5 million contract with VaxGen Inc. for a new anthrax vaccine, after problems with the vaccine's stability caused the company to miss a deadline for starting a clinical trial.